Retrospective Analysis of capsaïcin Patch in Complex Regional Pain Syndrome

Recruiting

• Conditions: Complex Regional Pain Syndromes

• Registration Number: NCT05523934
• Lead Sponsor: Brugmann University Hospital

Brief Summary

Complex regional pain syndrome is a painful syndrome often secondary to a traumatic lesion. Treatment is difficult, of long duration with variable outcomes. Patch of capsaïcin has been proposed as adjuvant to a multimodal treatment. Capsaïcin may act by its effect on transient receptor potential vanilloid 1. Efficacity and outcome studies with this treatment are lacking.

The aim of this retrospective study is to evaluate pain intensity over time assessed by visual analog scale in patient with complex regional pain syndrome treated with capsaïcin patch in addition to their usual treatment.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-08-29
• Study First Submitted QC: 2022-08-29
• Study First Posted: 2022-09-01
• Study Start: 2022-09-16
• Status Verified: 2023-07
• Last Update Submitted: 2023-07-26
• Last Update Posted: 2023-07-27
• Primary Completion: 2023-09-30
• Study Completion: 2023-10-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Adult patients with complex regional pain syndrome on maximum medical treatment
• Age ≥18 years
• Patients treated between 2012 and August 31, 2022 in the pain clinic of the CHU Brugmann

Exclusion Criteria

• incomplete medical chart

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain intensity	3 month period	Pain intensity evaluated by a visual analog scale (on a scale 0 to 10) by patients before and after capsaïcin addition.

Trial Locations

Locations (1)

CHU Brugmann; 🇧🇪 Brussels, Belgium